Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion type Assertion NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_head.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion description "[Standardized incidence rates for thyroid cancer were 72 [95% confidence interval (CI), 51-99; P < 0.001] for pathogenic PTEN mutations, 63 (95% CI, 42-92; P < 0.001) for SDHx variants, and 45 (95% CI, 26-73; P < 0.001) for KLLN epimutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_provenance.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion evidence source_evidence_literature NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_provenance.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion SIO_000772 21956414 NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_provenance.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion wasDerivedFrom befree-20150227 NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_provenance.
- NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_assertion wasGeneratedBy ECO_0000203 NP1013027.RAU3USEtUzDlgcdnyO0G2Af4hR1pzoV3y8oLEwzhY2kT4130_provenance.